Compare · PI vs TMO
PI vs TMO
Side-by-side comparison of Impinj Inc. (PI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- PI operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 47.0x PI ($4.21B).
- TMO has been more active in the news (9 items in the past 4 weeks vs 4 for PI).
- TMO has more recent analyst coverage (25 ratings vs 20 for PI).
- Company
- Impinj Inc.
- Thermo Fisher Scientific Inc
- Price
- $138.64-1.76%
- $532.16-2.05%
- Market cap
- $4.21B
- $197.88B
- 1M return
- +6.94%
- -
- 1Y return
- +19.49%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2016
- News (4w)
- 4
- 9
- Recent ratings
- 20
- 25
Impinj Inc.
Impinj, Inc. operates a cloud connectivity platform. Its platform, which comprises multiple product families, wirelessly connects individual items and delivers data about the connected items to business and consumer applications. The company's platform comprises endpoint ICs, a miniature radios-on-a-chip that attaches to a host item and includes a number to identify the item. Its platform also consists of systems products that comprise reader ICs, readers, and gateways to wirelessly provide power to and communicate bidirectionally with endpoint ICs on host items, as well as to read, write, authenticate, and engage the endpoint ICs on those items; and software and algorithms that enables its partners to deliver use cases, such as retail self-checkout and loss prevention, and warehouse pallet and carton tracking to end users. The company primarily serves retail, supply chain and logistics, aviation, automotive, healthcare, industrial and manufacturing, sports, food, datacenter, travel, banking, and linen and uniform tracking sectors through distributors, system integrators, value-added resellers, and software solution partners in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Impinj, Inc. was incorporated in 2000 and is headquartered in Seattle, Washington.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest PI
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. gifted 10,000 shares, decreasing direct ownership by 3% to 372,145 units (SEC Form 4)
- Impinj to Announce Second-Quarter 2026 Financial Results
- CHIEF FINANCIAL OFFICER Baker Cary converted options into 1,076 shares and covered exercise/tax liability with 424 shares, increasing direct ownership by 0.73% to 89,655 units (SEC Form 4) (withholding tax)
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. covered exercise/tax liability with 1,197 shares and converted options into 3,040 shares, increasing direct ownership by 0.48% to 382,145 units (SEC Form 4) (for tax liability)
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. gifted 10,000 shares, decreasing direct ownership by 3% to 380,302 units (SEC Form 4)
- Amendment: Director Sylebra Capital Llc sold $8,303,520 worth of shares (64,633 units at $128.47) (SEC Form 4)
- Director Sylebra Capital Llc sold $7,412,016 worth of shares (57,633 units at $128.61) (SEC Form 4)
- Director Sylebra Capital Llc sold $5,890,074 worth of shares (47,479 units at $124.06) (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. acquired $28,201,500 worth of shares (180,000 units at $156.68) as part of a pre-agreed trading plan and disposed of $28,201,500 worth of shares (180,000 units at $156.68) as part of a pre-agreed trading plan (SEC Form 4)
- Director Sylebra Capital Llc sold $4,572,215 worth of shares (33,412 units at $136.84) (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target